相关实验视频
Updated: Jan 18, 2026

20:59
Large Insert Environmental Genomic Library Production
Published on: September 23, 2009
16.4K
加拿大不列颠哥伦比亚省社区药房的地理位置
Alexander C T Tam1, L Olivia Tseng2,3, Wei Zhang1,4
1Centre for Advancing Health Outcomes, Providence Research, Vancouver, Canada.
Journal of pharmaceutical policy and practice
|January 16, 2026
概括
在加拿大不列颠哥伦比亚省 (BC) 在社区药房接入方面存在城市和农村的差异. 偏远社区,特别是人口较多的社区,在获得基本药房服务方面面临重大挑战.
科学领域:
- 药房实践 在药房实践.
- 医疗保健服务研究 医疗服务研究
- 地理信息系统 (GIS) 是指地理信息系统.
背景情况:
- 获得社区药房的机会对于医疗保健的提供至关重要.
- 获得医疗保健的地理差异越来越令人担忧.
- 在不列颠哥伦比亚省 (BC) 药房接入的城市和农村差异的程度以前是未知的.
研究的目的:
- 调查和描述在不列颠哥伦比亚省的城市和农村地区之间的社区药房接入的地理差异.
- 量化社区特征 (城市地位,人口) 和药房可达性之间的关系.
主要方法:
- 使用公开可用的地理空间数据进行了地理信息系统 (GIS) 分析.
- 在BC的社区药房位置,道路网络和社区边界被利用.
- 对每个药房定义了一个5公里的服务区域,并计算出每个社区可访问的药房的数量.
主要成果:
- 该分析包括1528家社区药房和231个地理社区.
- 所有中型/大型城市社区都有五家或更多的药房.
- 随着越来越多的农村地区,获得医药的机会减少了;17个偏远社区中,有0个可以获得5家或更多的药房,14个偏远社区可以获得1家或零家药房.
结论:
- 在不列颠哥伦比亚省,在社区药房的准入方面存在明显的城乡差异.
- 偏远社区及其居民在进入社区药房方面面临重大障碍.
- 地理信息系统分析有效地突出了医疗保健服务分配中的地理不平等.
相关概念视频
Primary Healthcare Services
2.0K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.0K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
189
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
189
Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
Biopharmaceutics and Pharmacokinetics: Overview
3.4K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.4K
Drug Delivery: Parenteral Route
1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K
Hepatic Drug Clearance: Role of Transporters
297
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
297

